EP3980561 - COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.04.2024 Database last updated on 24.08.2024 | |
Former | Request for examination was made Status updated on 11.03.2022 | ||
Former | The international publication has been made Status updated on 11.12.2020 | ||
Former | unknown Status updated on 17.06.2020 | Most recent event Tooltip | 19.04.2024 | Application deemed to be withdrawn | published on 22.05.2024 [2024/21] | Applicant(s) | For all designated states Sitokine Limited 2 Duke Street London W1U 3EH / GB | [2022/15] | Inventor(s) | 01 /
KORNMAN, Kenneth S. 920 Centre Street Newton, Massachusetts 02459 / US | 02 /
DOUCETTE-STAMM, Lynn 14 Flanagan Drive Framingham, Massachusetts 01701 / US | 03 /
DUFF, Gordon W. 18 Ashgate Road Sheffield South Yorkshire S10 3BZ / GB | [2022/15] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [2022/15] | Application number, filing date | 20731071.5 | 05.06.2020 | [2022/15] | WO2020EP65692 | Priority number, date | US201962858147P | 06.06.2019 Original published format: US 201962858147 P | [2022/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020245402 | Date: | 10.12.2020 | Language: | EN | [2020/50] | Type: | A1 Application with search report | No.: | EP3980561 | Date: | 13.04.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.12.2020 takes the place of the publication of the European patent application. | [2022/15] | Search report(s) | International search report - published on: | EP | 10.12.2020 | Classification | IPC: | C12Q1/6886 | [2022/15] | CPC: |
C12Q1/6886 (EP,US);
A61K39/3955 (US);
A61K31/136 (US);
A61K31/196 (US);
A61K31/325 (US);
A61K31/337 (US);
A61K31/404 (US);
A61K31/407 (US);
A61K31/4184 (US);
A61K31/436 (US);
A61K31/444 (US);
A61K31/4545 (US);
A61K31/4706 (US);
A61K31/4745 (US);
A61K31/475 (US);
A61K31/506 (US);
A61K31/513 (US);
A61K31/517 (US);
A61K31/519 (US);
A61K31/5377 (US);
A61K31/675 (US);
A61K31/704 (US);
A61K31/7048 (US);
A61K31/7068 (US);
A61K38/12 (US);
A61K38/14 (US);
A61P35/00 (US);
C07K16/245 (US);
C07K16/248 (US);
G01N33/57419 (US);
G01N33/57423 (US);
C12Q2600/106 (EP);
C12Q2600/118 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/15] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON LUNGEN-, KOLOREKTAL- UND BRUSTKREBS | [2022/15] | English: | COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER | [2022/15] | French: | COMPOSITIONS ET MÉTHODES DE TRAITEMENT DES CARCINOMES PULMONAIRES, COLORECTAUX ET MAMMAIRES | [2022/15] | Entry into regional phase | 05.01.2022 | National basic fee paid | 05.01.2022 | Designation fee(s) paid | 05.01.2022 | Examination fee paid | Examination procedure | 05.01.2022 | Examination requested [2022/15] | 05.01.2022 | Date on which the examining division has become responsible | 22.07.2022 | Amendment by applicant (claims and/or description) | 03.01.2024 | Application deemed to be withdrawn, date of legal effect [2024/21] | 23.01.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2024/21] | Fees paid | Renewal fee | 27.06.2022 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.06.2023 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2017198350 (DOUCETTE-STAMM LYNN [US], et al) [Y] 1-156 * claims 1-8,38-48,85-88 * * paragraphs [0032] - [0042] - [0044] , [0051] - [0052] - [0056] , [0063] - [0069] * * tables 1-2 *; | [Y]WO2018234879 (NOVARTIS AG [CH]) [Y] 1-156 * claims 1-14,19,27,28,49,59 * * page 12, paragraph 2 - page 15, paragraph 1 *; | [Y] - TATIANA ZAMAY ET AL, "Current and Prospective Protein Biomarkers of Lung Cancer", CANCERS, (20171113), vol. 9, no. 12, doi:10.3390/cancers9110155, page 155, XP055725584 [Y] 17,57,79 * the whole document * * table 1 * DOI: http://dx.doi.org/10.3390/cancers9110155 | [Y] - HUMAID O. AL-SHAMSI ET AL, "Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern", JOURNAL OF GASTROINTESTINAL ONCOLOGY, (20161201), vol. 7, no. 6, doi:10.21037/jgo.2016.11.02, ISSN 2078-6891, pages 882 - 902, XP055725587 [Y] 32-34,38,42,83-85,89,90,110 * the whole document * * table 2 * DOI: http://dx.doi.org/10.21037/jgo.2016.11.02 | [Y] - D. Zhang C. Bao H. Qian, "Two variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study", AGING, (20181219), pages 4084 - 4092, URL: https://paperchase-aging.s3-us-west-1.amazonaws.com/pdf/QmgtQHNJ5vd8747RJ.pdf, (20200825), XP055724820 [Y] 1-156 * the whole document * DOI: http://dx.doi.org/10.18632/aging.101695 | [Y] - XIAOAN LIU ET AL, "Three polymorphisms in interleukin-1Î2 gene and risk for breast cancer: a meta-analysis", BREAST CANCER RESEARCH AND TREATMENT, KLUWER ACADEMIC PUBLISHERS, BO, (20100501), vol. 124, no. 3, doi:10.1007/S10549-010-0910-3, ISSN 1573-7217, pages 821 - 825, XP019859280 [Y] 1-156 * the whole document * DOI: http://dx.doi.org/10.1007/s10549-010-0910-3 | [Y] - WU K S ET AL, "Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 411, no. 19-20, ISSN 0009-8981, (20101009), pages 1441 - 1446, (20100604), XP027170965 [Y] 1-156 * the whole document * | [Y] - KEITH D. EATON ET AL, "Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility", JOURNAL OF THORACIC ONCOLOGY, US, (20180501), vol. 13, no. 5, doi:10.1016/j.jtho.2018.01.022, ISSN 1556-0864, pages 649 - 659, XP055724883 [Y] 1-156 * the whole document * DOI: http://dx.doi.org/10.1016/j.jtho.2018.01.022 | [Y] - BALASUBRAMANIAN SP ET AL, "Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20060714), vol. 6, no. 1, doi:10.1186/1471-2407-6-188, ISSN 1471-2407, page 188, XP021016183 [Y] 1-56 * the whole document * DOI: http://dx.doi.org/10.1186/1471-2407-6-188 | [Y] - A. L. VAN DYKE ET AL, "Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non-Small Cell Lung Cancer among Women", CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION, (20090601), vol. 18, no. 6, doi:10.1158/1055-9965.EPI-08-0962, ISSN 1055-9965, pages 1829 - 1840, XP055725150 [Y] 1-156 * the whole document * * table 2 * * page 1835, column 1, paragraph 2 - page 1838, column 2 * DOI: http://dx.doi.org/10.1158/1055-9965.EPI-08-0962 | [Y] - KRISTINA L. BONDURANT ET AL, "Interleukin genes and associations with colon and rectal cancer risk and overall survival", INTERNATIONAL JOURNAL OF CANCER, US, (20120626), vol. 132, no. 4, doi:10.1002/ijc.27660, ISSN 0020-7136, pages 905 - 915, XP055725157 [Y] 1-156 * the whole document * DOI: http://dx.doi.org/10.1002/ijc.27660 | by applicant | US4683195 | US4683202 | EP0235726 | WO8911548 | US4988617 | US4988167 | US5118801 | US5210015 | WO9322456 | US5270184 | US5312728 | WO9416101 | US5399491 | US5422252 | US5494810 | US5498531 | US5527675 | US5539082 | US5538848 | US5623049 | WO9731256 | US5686246 | US5698399 | US5714331 | US5808918 | US5830711 | US5866336 | US6027923 | US6027889 | US6054564 | US6108635 | US6117635 | WO0056927 | US6140047 | US6210877 | US6251598 | US6268148 | US6268142 | US6383775 | US6437216 | US2002182612 | US6524795 | US6551785 | US6558905 | US2003100031 | US2003124524 | US2003152947 | US2003175764 | US2003235890 | US6706478 | US6713253 | US6720141 | US6730476 | US6733967 | US6746839 | US2004110168 | US2004152124 | US2005032077 | US2005064453 | US2005171338 | US2005282198 | US2006183161 | US2006252050 | US2007264645 | US2007275104 | US2008118920 | US2008187920 | US2008199865 | US2008254476 | US2008254477 | US2008254478 | US2008311581 | US2009023147 | US2009093396 | US2009163460 | US2009170105 | US2009191564 | US2010028893 | US2010098775 | US2010098809 | US2010105038 | US2010112570 | US7723028 | US2010129798 | US2010136561 | US2010255475 | US7820383 | US2010279280 | US2011008906 | US8101360 | US8105775 | US2012208187 | US2013011841 | US2013337448 | - LI et al., Proc Natl Acad Sci USA., (20030000), vol. 100, no. 5, pages 2674 - 8 | - SONG ZYUN LINYE XFENG CLU Y et al., "IL-la and IL-6 expression in cervical cancer", Med Sci Monit, (20160000), vol. 22, pages 4475 - 4481 | - WUWALLACE, Genomics, (19890000), vol. 4, page 560 | - LANDEGREN et al., Science, (19880000), vol. 241, page 1077 | - GUATELLI et al., Proc Natl Acad Sci USA, (19900000), vol. 87, page 1874 | - KWOK, "Methods for genotyping single nucleotide polymorphisms", Annu Rev Genom Hum Genet, (20010000), vol. 2, doi:10.1146/annurev.genom.2.1.235, pages 235 - 58, XP001153175 DOI: http://dx.doi.org/10.1146/annurev.genom.2.1.235 | - COREY, "Peptide nucleic acids: expanding the scope of nucleic acid recognition", Trends Biotechnol, (19970600), vol. 15, no. 6, doi:10.1016/S0167-7799(97)01037-8, pages 224 - 9, XP004064511 DOI: http://dx.doi.org/10.1016/S0167-7799(97)01037-8 | - HYRUP et al., "Peptide nucleic acids (PNA): synthesis, properties and potential applications", Bioorg Med Chem, (19960100), vol. 4, no. 1, doi:10.1016/0968-0896(95)00171-9, pages 5 - 23, XP000602327 DOI: http://dx.doi.org/10.1016/0968-0896(95)00171-9 | - MYERS et al., Nature, (19850000), vol. I ; II, page 495 | - SAIKI et al., Nature, (19860000), vol. I-IV, pages 163 - 166 | - KINZLER KWVOGELSTEIN B., "Landscaping the cancer terrain", Science, (19980000), vol. 154 ; 155, pages 1036 - 1037 | - GIBBS, Nucleic Acid Res, (19890000), vol. 17, pages 2427 - 2448 | - LIVAK et al., PCR Method Appl, (19950000), vol. 4, pages 357 - 362 | - TYAGI et al., Nature Biotechnology, (19960000), vol. 14, pages 303 - 308 | - NAZARENKO et al., Nuc' Acids Res, (19970000), vol. 25, pages 2516 - 2521 | - SRIVATSAN et al., PLoS Genet, (20080000), vol. 4, page el00139 | - RASMUSSEN et al., Nature, (20100000), vol. 463, pages 311 - 317 | - PELAK et al., PLoS Genet, (20100000), vol. 6, page elOOl 111 | - RAM et al., Syst Biol Reprod Med, (20110000), vol. 57, no. 3, pages 117 - 118 | - MCELLISTREM, Future Microbiol, (20090000), vol. 4, pages 857 - 865 | - LO et al., Clin Chem, (20090000), vol. 55, pages 607 - 608 | - ROBINSON, Genome Biol, (20100000), vol. 11, page 144 | - CHEN et al., "Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput", Pharmacogenomics J, (20030000), vol. 3, no. 2, doi:10.1038/sj.tpj.6500167, pages 77 - 96, XP009088626 DOI: http://dx.doi.org/10.1038/sj.tpj.6500167 | - KWOK et al., "Detection of single nucleotide polymorphisms", Curr Issues Mol Biol, (20030400), vol. 5, no. 2, pages 43 - 60 | - SHI, "Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes", Am J Pharmacogenomics, (20020000), vol. 2, no. 3, doi:10.2165/00129785-200202030-00005, pages 197 - 205, XP009065150 DOI: http://dx.doi.org/10.2165/00129785-200202030-00005 | - MAMELLOS, "High-throughput SNP analysis for genetic association studies", Curr Opin Drug Disc Devel, (20030500), vol. 6, no. 3, pages 317 - 21 | - WISE et al., "A standard protocol for single nucleotide primer extension in the human genome using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry", Rapid Comm. Mass Spect, (20030000), vol. 17, no. 11, pages 1195 - 202 | - COHEN et al., Adv Chromatogr, (19960000), vol. 36, pages 127 - 162 | - GRIFFIN et al., Appl Biochem Biotechnol, (19930000), vol. 38, pages 147 - 159 | - ORITA et al., Proc. Nat. Acad | - RIDKER P.M.BURING J.ECOOK N.R.RIFAI N., "C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy american women", Circulation, (20030000), vol. 107, pages 391 - 397 | - RIDKER P.MDANIELSON EFONSECA F.A et al., "Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein", The New England Journal of Medicine, (20080000), vol. 359, pages 2195 - 2207 | - RIDKER P.M.HENNEKENS C.H.BURING J.E.RIFAI N, "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women", The New England Journal of Medicine, (20000000), vol. 342, doi:10.1056/NEJM200003233421202, pages 836 - 843, XP009035223 DOI: http://dx.doi.org/10.1056/NEJM200003233421202 | - NETEA M.G.BALKWILL FCHONCHOL M et al., "A guiding map for inflammation", Nat Immunol, (20170000), vol. 18, pages 826 - 831 | - RIDKER P.M.EVERETT B.M.THUREN T. et al., "Antiinflammatory therapy with canakinumab for atherosclerotic disease", The New England Journal of Medicine, (20170000), vol. 377, doi:10.1056/NEJMoa1707914, pages 1119 - 1131, XP055524405 DOI: http://dx.doi.org/10.1056/NEJMoa1707914 | - RIDKER P.M.MACFADYEN J.G.EVERETT B.M. et al., "Relationship of c-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial", Lancet, (20180000), vol. 391, pages 319 - 328 | - RIDKER P.M.MACFADYEN J.G.THUREN T et al., "Effect of interleukin-lbeta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial", Lancet, (20170000), vol. 390, pages 1833 - 1842 | - RIDKER PM, "Anti-inflammatory therapy for atherosclerosis: interpreting divergent results from the CANTOS and CIRT clinical trials", J Intern Med, (20190000), vol. 285, pages 503 - 9 | - ADAY AWRIDKER PM, "Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease", Front Cardiovasc Med, (20190000), vol. 6, page 16 | - AGGARWAL BBSHISHODIA SSANDUR SKPANDEY MKSETHI G., "Inflammation and cancer: how hot is the link?", Biochem Pharmacol, (20060000), vol. 72, doi:10.1016/j.bcp.2006.06.029, pages 1605 - 21, XP025043230 DOI: http://dx.doi.org/10.1016/j.bcp.2006.06.029 | - AGGARWAL BBVIJAYALEKSHMI RVSUNG B., "Targeting inflammatory pathways for prevention and therapy of cancer: Short-term friend, long-term foe", Clin Cancer Res, (20090000), vol. 15, pages 425 - 430 | - APTE R NDVORKIN TSONG XFIMA E et al., "Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness", Adv. Exp. Med. Biol., (20000000), vol. 479, pages 277 - 288 | - BALKWILL FRMANTOVANI A., "Cancer-related inflammation: common themes and therapeutic opportunities", Semin. Cancer Biol., (20120000), vol. 22, doi:10.1016/j.semcancer.2011.12.005, pages 33 - 40, XP028897445 DOI: http://dx.doi.org/10.1016/j.semcancer.2011.12.005 | - BANI, M. R.GAROFALO, A.SCANZIANI, E.GIAVAZZI, R., "Effect of interleukin-1-beta on metastasis formation in different tumor systems", J. Natl. Cancer Ins., (19910000), vol. 83, no. 2, pages 119 - 123 | - BASU AKRADY JKLEVISON SW, "Interleukin-1: a master regulator of neuroinflammation", J Neurosci Res, (20040000), vol. 78, pages 151 - 156 | - BERSE, BHUNT JADIEGEL RJMORGANELLI PYEO KBROWN F et al., "Hypoxia augments cytokine (transforming growth factor-beta (TGFbeta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts", Clin. Exp. Immunol, (19990000), vol. 115, pages 176 - 182 | - BERGER PMCCONNELL JPNUNN M et al., "C-reactive protein levels are influenced by common IL-1 gene variations", Cytokine, (20020000), vol. 17, pages 171 - 174 | - CARMI, Y.VORONOV, E.DOTAN, S.LAHAT, N.RAHAT, M. A.FOGEL, M. et al., "The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis", J Immunol, (20090000), vol. 183, pages 4705 - 4714 | - CHEN HWILKINS LMAZIZ N et al., "Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context", Hum Mol Genet, (20060000), vol. 15, doi:10.1093/hmg/ddi469, pages 519 - 529, XP002437353 DOI: http://dx.doi.org/10.1093/hmg/ddi469 | - COUSSENS LMWERB Z., "Inflammation and cancer", Nature, (20020000), vol. 420, pages 60 - 867 | - DINARELLO C A, "Biologic basis for interleukin-1 in disease", Blood, (19960000), vol. 87, no. 6, pages 2095 - 2147, XP000574933 | - FARROW BEVERS BM., "Inflammation and the development of pancreatic cancer", Surg Oncol, (20020000), vol. 10, pages 153 - 169 | - FEDERICO AMORGILLO FTUCCILLO CCIARDIELLO FLOGUERCIO C, "Chronic inflammation and oxidative stress in human carcinogenesis", Int. J. Cancer, (20070000), vol. 121, pages 2381 - 86 | - FERNANDES JVFERNANDES TAADE AZEVEDO JCVCOBUCCI RNO et al., "Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review", Oncology Letters, (20150000), vol. 9, pages 1015 - 1026 | - GRIVENNIKOV SIGRETEN FRKARIN M, "Immunity, inflammation, and cancer", Cell, (20100000), vol. 140, doi:10.1016/j.cell.2010.01.025, pages 883 - 899, XP055369021 DOI: http://dx.doi.org/10.1016/j.cell.2010.01.025 | - HE QFU YTIAN DYAN W., "The contrasting roles of inflammasomes in cancer", Am J Cancer Res, (20180000), vol. 8, no. 4, pages 566 - 583 | - HUSSAIN SPHARRIS CC., "Inflammation and cancer: An ancient link with novel potentials", Int. J. Cancer, (20070000), vol. 121, pages 2373 - 80 | - JENG JHWANG YJCHIANG BLLEE PHCHAN CP et al., "Roles of keratinocyte inflammation in oral cancer: Regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline", Carcinogenesis, vol. 24, pages 1301 - 1315 | - JUNG YJ1ISAACS JSLEE STREPEL JNECKERS L., "IL-lbeta-mediated up-regulation of HIF-1 alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis", FASEB j, (20030000), vol. 17, no. 14, pages 2115 - 17 | - KIYOHARA, CHORIUCHI TTAKAYAMA KNAKANISHI Y., "IIL 10 rsl 143634 Polymorphism, Cigarette Smoking, Alcohol Use, and Lung Cancer Risk in a Japanese Population", J Thorac Oncol, (20100000), vol. 5, pages 299 - 304 | - KRELIN Y et al., "Interleukin-lbeta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors", Cancer Res, (20070000), vol. 67, pages 1062 - 71 | - KURTZMAN SHANDERSON KHWANG Y et al., "Cytokines in human breast cancer: IL-1 alpha and IL-lbeta expression", Oncol Rep, (19990000), vol. 6, pages 65 - 70 | - LANDVIK NEHART KHAUGEN AZIENOLDDINY S, "Functional analysis of a lung cancer risk haplotype in the IL1B gene regulatory region", J Hum Genet, (20120000), vol. 57, pages 747 - 752 | - LANDVIK NEHART KSKAUG VSTANGELAND LBHAUGEN AZIENOLDDINY S, "A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer", Carcinogenesis, (20090000), vol. 30, pages 1186 - 1192 | - LEE KMPARK SKHAMAJIMA NTAJIMA K et al., "Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women", Breast Cancer Res Treat, (20060000), vol. 96, no. 2, pages 197 - 202, XP019274996 | - LEE CHCHANG JSMSYU SHWONG TS, "IL-1 β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer", J Cell Physiol, (20150000), vol. 230, pages 875 - 884 | - LI YWANG LPAPPAN LGALLIHER-BECKLEY ASHI J., "IL-IØ promotes sternness and invasiveness of colon cancer cells through Zebl activation", Mol Cancer, (20120000), vol. 11, pages 87 - 99 | - LISS, C.FEKETE, M. J.HASINA, R.LAM, C. D.LINGEN, M. W., "Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages", Int. J. Cancer, (20010000), vol. 93, no. 6, pages 781 - 785 | - LIU QRUSSELL MRSHAHRIARI K et al., "Interleukin-1 beta promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features", Cancer Res, (20130000), vol. 73, pages 3297 - 305 | - LUST JADONOVAN KA, "The role of interleukin-1 beta in the pathogenesis of multiple myeloma", Hematol. Oncol. Clin. North Am., (19990000), vol. 13, pages 1117 - 25 | - LUST JA et al., "Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 10-induced interleukin 6 production and the myeloma proliferative component", Mayo Clin. Proc., (20090000), vol. 84, pages 114 - 22, XP055695323 | - MARUYAMA, K.MORI, Y.MURASAWA, S.MASAKI, H.TAKAHASHI, N.TSUTUSMI, Y. et al., "Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases", J. Mol. Cell. Cardiol, (19990000), vol. 31, pages 607 - 617 | - MICHAUD, D. S. et al., "Periodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study", JNCI J Natl Cancer Inst, (20180000), vol. 110, no. 8, page djx278 | - MITSUNAGA SIKEDA MSHIMIZU SOHNO IFURUSE J et al., "Serum levels of IL-6 and IL-Iβ can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer", Br J Cancer, (20130000), vol. 108, no. 10, pages 2063 - 9 | - MOHR THAUDEK-PRINZ VSLANY AGRILLARI JMICKSCHE MGERNER C, "Proteome profiling in IL-Iβ and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis", PLoS ONE, (20170000), vol. 12, no. 6, page e0179065 | - NADINI ACARRARO F, "Role of Inflammatory Mediators in Angiogenesis", Curr Drug Targ- Inflamm & Allergy, (20050000), vol. 4, pages 3 - 8 | - NASU, K.ITOH, H.YUGE, A.KAWANO, Y.YOSHIMATSU, J.NARAHARA, H., "Interleukin-lbeta regulates vascular endothelial growth factor and soluble fmslike tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts", Gynecol. Endocrinol, (20060000), vol. 22, pages 495 - 500 | - NUTTER FHOLEN IBROWN HKCROSS SSEVANS CAWALKER MCOLEMAN REWESTBROOK JASELBY PJBROWN JE et al., "Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line", Endocr Relat Cancer, (20140000), vol. 21, pages 327 - 341 | - OHSHIMA, M. TATEMICHIT. SAWA., "Chemical basis of inflammation-induced carcinogenesis", Archives of Biochemistry and Biophysics, (20030000), vol. 417, no. 1, doi:10.1016/S0003-9861(03)00283-2, pages 3 - 11, XP004444532 DOI: http://dx.doi.org/10.1016/S0003-9861(03)00283-2 | - OHNISHI SMA NTHANAN RPINLAOR S et al., "DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells", Oxid Med Cell Longev, (20130000), vol. 2013, page 387014 | - OZBABACAN SEAGURSOY ANUSSINOV RKESKIN O, "The Structural Pathway of Interleukin 1 (IL-1) Initiated Signaling Reveals Mechanisms of Oncogenic Mutations and SNPs in Inflammation and Cancer", PLoS Comput Biol, (20140000), vol. 10, no. 2, page el003470 | - PELETEIRO BLUNET NCARRILHO CDURAES C et al., "Association Between Cytokine Gene Polymorphisms and Gastric Precancerous Lesions: Systematic Review and Meta-analysis", Cancer Epidemiol Biomarkers Prev, (20100000), vol. 19, no. 3, pages 62 - 76 | - RAO SKPAVICEVIC ZDU ZKIM JGFAN MJIAO YROSEBUSH MSAMANT SGU WPFEFFER LM, "Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma", J Biol Chem, (20100000), vol. 285, pages 32512 - 21 | - ROGUS JBECK JDOFFENBACHER S et al., "IL1B gene promoter haplotype pairs predict clinical levels of interleukin-lbeta and C-reactive protein", Hum Genet, (20080000), vol. 123, pages 387 - 398, XP019631027 | - SANABRIA-SALAS MCHERNANDEZ-SUAREZ GUMANA-PEREZ A et al., "IL1B-CGTC haplotype is associated with colorectal cancer in admixed subjects with increased African ancestry", Sci Rep, (20170000), vol. 7, page 41920 | - SCHNEIDER SROSS AGRICHNIK JM, "Do inflammatory pathways drive melanomagenesis?", Experiment Dermat, (20140000), vol. 24, pages 86 - 90 | - STAVRI GTZACHARY I CBASKERVILLE P AMARTIN, J FERUSALIMSKY J D., "Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia", Circulation, (19950000), vol. 92, pages 11 - 14 | - TAKAHASHI HOGATA HNISHIGAKI RBROIDE DHMICHAEL KARIN M., "Tobacco Smoke Promotes Lung Tumorigenesis by Triggering IKKβ and JNK1-Dependent Inflammation", Cancer Cell, (20090000), vol. 17, pages 89 - 97 | - TANG RFWANG SXZHANG FR et al., "Interleukin-l alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer", Hepatobiliary Pancreat Dis Int, vol. 4, pages 460 - 63 | - TARASSISHIN LLIM JWEATHERLY DBANGELETTI RHLEE SC, "Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression", J Proteomics, (20140000), vol. 99C, doi:10.1016/j.jprot.2014.01.024, pages 152 - 168, XP028625154 DOI: http://dx.doi.org/10.1016/j.jprot.2014.01.024 | - TARASSISHIN LCASPER DLEE SC, "Aberrant Expression of Interleukin-lb and Inflammasome Activation in Human Malignant Gliomas", PLoS ONE, (20140000), vol. 9, no. 7, page e103432 | - THORNTON PPINTEAUX EGIBSON RMALLAN SMROTHWELL NJ, "Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release", JNeurochem, (20060000), vol. 98, pages 258 - 266 | - VINCENZI BPATTI GGALLUZZO SPANTANO F et al., "Interleukin 1B-51 IT gene (IL1B) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis", Oncology Reports, (20080000), vol. 20, pages 1213 - 1220 | - VORONOV ECARMI YAPTE RN, "The role of IL-lintumor-mediated angiogenesis", Frontiers Physiol, (20140000), vol. 5 | - WANG LLIU ZLI Y et al., "Pro-inflammatory cytokine interleukin-ip promotes the development of intestinal stem cells", Inflamm Res, (20120000), vol. 61, pages 1085 - 1092 | - WANG LZHANG LFWU JXU SJXU YY et al., "IL-lb-Mediated Repression of microRNA-101 Is Crucial for Inflammation-Promoted Lung Tumorigenesis", Cancer Res, (20140000), vol. 74, no. 17, pages 4720 - 30 | - WANG YWANG KHAN GCWANG RX et al., "Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis", Nature, (20140000), vol. 7, no. 5, pages 1106 - 15 | - WEINREICH, D. M.ELARAJ, D. M.PUHLMANN, M.HEWITT, S. M. et al., "The role of interleukin 1 in growth and metastasis of human cancer xenografts", Cancer Res, (20030000), vol. 63, no. 18, pages 5957 - 5961 | - WHITCOMB, DAVID C., "Inflammation and Cancer. V. Chronic pancreatitis and pancreatic cancer", Am J Physiol Gastrointest Liver Physiol, (20040000), vol. 287, pages G315 - G319 | - WOLF JSCHEN ZDONG G et al., "IL (interleukin)-1 alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas", Clin Cancer Res, (20010000), vol. 7, pages 1812 - 20 | - XU J1YIN ZCAO SGAO W et al., "Systematic review and meta-analysis on the association between IL-1B polymorphisms and cancer risk", PLoS One, (20130521), vol. 8, no. 5, page e63654 | - XU HDING QJIANG HW, "Genetic polymorphism of interleukin-1A (IL-1A), IL-1B, and IL-1 receptor antagonist (IL-1RN) and prostate cancer risk", Asian Pac J Cancer Prev, (20140000), vol. 15, no. 20, pages 8741 - 7 | - LEE, C. H.S. H. SYUK. J. LIUP. Y. CHUW. C. YANGP. LINW. Y. SHIEH, "Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer", Oncotarget, (20150000), vol. 6, no. 36, pages 38866 - 38880 | - MICHAUD et al., JNCI Natl Cancer Inst, (20180000), vol. 11, no. 8, page djx278 | US20050095849 | US20180604278 | US19360604456 | US19940604454 |